.png){kind=logo}
Midterml Exam:l NRl 568/l NR568l (Latestl
2026/l 2027l Update)l Advancedl Pharmacologyl forl thel Adult-Gerontologyl Primaryl Carel Nursel Practitionerl Guidel |Q/Al |l Gradel A|l 100%l Correctl (Verifiedl Answers)l -Chamberlain
Q:l Treatmentl forl Tineal Crurisl (ringworml ofl thel groin)
Answer:
Topicall worksl welll andl shouldl bel continuel 1l weekl afterl thel symptomsl havel cleared.l Ifl Severe,l givel systemicl antigungall likel Clotrimazolel orl bothl topicall andl systemicl glucocorticoidsl mayl bel neededl asl well.l T.B.Cl ifl severe
Q:l Treatmentl forl Tineal Pedisl (ringworml ofl thel footl orl athletesl foot)
Answer:
T.B Terbinafine BUtenafine
Q:l Treatmentl forl Tineal Corporisl (ringworml ofl thel body)
Answer:
Topicall Azolel orl Allylaminel andl shouldl bel continuedl 1l weekl afterl thel symptomsl hasl cleared.Forl severel casesl -l systemicl anti-fungall agentl likel griseofulvinl isl givenT.B
- / 4
Q:l Tineal Capitisl (ringworml ofl thel scalp)
Answer:
Orall griseofulvinl shouldl bel takel 6l tol 8l weeksl asl al standardl therapy.l orl Orall Terbinafinel whichl canl bel takel forl 2l tol 4l weeksl (morel effective)l G.T
Q:l Treatmentl forl orall candidiasisl (thrush)
Answer:
Topicall agentsl -l nystatin,l clotrimaozlel andl miconazolel Ifl immunocompromisedl host,l orall therapyl ofl flucanozalel orl ketoconazole
Q:l Treatmentl forl asperigillosisl (farmersl lung)
Answer:
drugl ofl choicel isl voriconazolel
altl drugs:l A.B.I.I.PC.Ml
Amphotericinl B Isavuconazoniuml Itraconazole Posaconazolel Caspofunginl Micafungin
Q:l Whatl dol youl avoidl tol combinel withl Voriconazole?
Answer:
Phenobarbital.l Becausel itl isl al CYP450l inducerl thatl ifl givenl withl Voriconazolel willl impactl thel levelsl andl willl notl bel ablel tol reachl thel therapeuticl level.
Q:l Patientl teachingl ofl Itraconazole
- / 4
Answer:
Avoidl combingl withl drugsl thatl metabolizel byl CYP3A4 Takel PPIsl atl leastl 1l hourl beforel orl itraconazolel 2l hoursl afterl Andl instructl tol watchl forl signsl ofl liverl dysfunction.
Q:l Examplel ofl al nucleotidel reversel transcriptasel inhibitorl -l NRTIl drug
Answer:
Abacavir
Q:l Diagnosticl andl Monitoringl forl Anthelmintics
Answer:
Albendazolel -l liverl function,l cbcl withl diffl andl RFTl Prazuquantell -l LFTl Ivermecticl andl Moxidecticl -l Opthalmologicl examl ifl baselinel isl abnormal
Q:l CYP4A
Answer:
W.C.D.Ql "Wel Canl D.Q" Warfarin Cyclosporin Digozinl Quinidine
Q:l Adversel effectl ofl Itraconazole
Answer:
Canl causel cardiacl supperession,l liverl injuryl andl GIl issues.l Canl alsol causel rash,l headache,l edema,l abdominall pain.
Q:l Highl riskl patientsl withl Albendazole 3 / 4
Answer:
Impairedl liverl andl renall function,l anemia,l bleedingl disorderl andl infection.
Q:l Highl riskl patientsl withl Mebendazole
Answer:
Liverl disease,l anemia,l bleedingl disorderl andl infection
Q:l Highl riskl patientsl withl Pyrantell Pamoate
Answer:
Liverl impairment,l neonatesl shouldl notl bel prescribedl formualationl containingl benzyll alcoholl orl itsl derivatives
Q:l Highl riskl patientsl withl Ivermecticl andl Moxidectic
Answer:
Hytpotensionl orl takingl anithypertensivel drugs
Q:l Highl riskl patientsl withl Didanosine
Answer:
Riskl forl pancreatitisl isl increasel byl al historyl ofl alcoholisml orl pancreatitisl andl byl usel ofl IVl pentamidine
Q:l Highl riskl patientsl withl Zidovudine
Answer:
Riskl forl hematologicl toxicityl isl increasel byl al lowl granulocytel count;l lowl levelsl ofl hemoglobin,l b12l orl folicl acid,l concurrentl usel ofl drugsl thatl arel myelosuppressive,l nephrotoxicl orl toxicl tol circulatingl bloodl cells.
- / 4
.png)